GLP Watchdog

Eloria vs TrimRx

Neither Eloria nor TrimRx has an FDA warning letter on record. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $299 at Eloria and $299 at TrimRx.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Eloria / TrimRx

Eloria logo

Eloria

6.5/10

TrimRx logo

TrimRx

6.4/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$299/moCompounded semaglutide injection
$299/moCompounded semaglutide injection
States
No state list published
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit EloriaFull review
Visit TrimRxFull review

Neither Eloria nor TrimRx pays us. Links to them earn nothing. Scores: Eloria 6.5, TrimRx 6.4. How we are paid

What the record shows

  1. 01

    Neither Eloria nor TrimRx has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $299 at Eloria and $299 at TrimRx.

  4. 04

    Only TrimRx lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Eloria

TrimRx

Compounded semaglutide injection

$299/mo

$3,588 a year

$299/mo

$3,588 a year

Compounded tirzepatide injection

$399/mo

$4,788 a year

$399/mo

$4,788 a year

Brand-name semaglutide pen
Not sold or not priced

$1,299/mo

$15,588 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,399/mo

$16,788 a year

Price includes
Medication, clinician visits, shipping, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Month-to-month has none; longer plans are paid in advance
None on the monthly plan; multi-month plans are prepaid
Refunds
Full refund before an order reaches the pharmacy; prepaid plans refunded minus the 3-month price per package sent
Full refund if a provider finds you ineligible; other refund requests within 28 days of payment
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Eloria: October 17, 2026. TrimRx: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Eloria

6.5/10

The record gives Eloria no edge on this pair.

  • Names no compounding pharmacy
Visit Eloria

The case for TrimRx

6.4/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Eloria does not price
  • Names no compounding pharmacy
Visit TrimRx

Scores

Eloria 6.5 · TrimRx 6.4 out of 10. Six weighted parts.

Value25%

2.1A
vs
B
2.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

8.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Eloria vs TrimRx: questions

Neither Eloria nor TrimRx has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Neither, by more than $1 a month. Eloria charges $299 a month and TrimRx $299 a month.
Eloria states you can cancel at any time; refunds: full refund before an order reaches the pharmacy; prepaid plans refunded minus the 3-month price per package sent. TrimRx states you can cancel at any time; refunds: full refund if a provider finds you ineligible; other refund requests within 28 days of payment.
Neither Eloria nor TrimRx pays us. Links to them earn nothing. Scores: Eloria 6.5, TrimRx 6.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks